December 22, 2009 08:30 ET

ONE Bio Retains Capital Group Communications as Strategic Investor Relations Consulting Firm

MIAMI, FL--(Marketwire - December 22, 2009) - ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that it has retained Capital Group Communications ("CGC") for its Public and Investor relations efforts.

Upon completing its reverse merger in June of 2009, ONE has had many accomplishments in the US Capital Markets:

   1)  The company completed a 5 to 1 reverse split and has submitted an
       application for listing on NASDAQ Capital Markets.
   2)  The company has made a few significant acquisitions in high growth
       market segments.
         a. ONE Bio's Organic Product (OP) division was created through the
            acquisition of Jianou Lujian. The OP division develops organic
            health food and agricultural products and extracts derived
            mainly from bamboo.
         b. ONE Bio's Chemical and Herbal Extract (CHE) business was
            created through the acquisition of Green Planet Bioengineering.
            The CHE division extracts produces key chemical intermediates
            found in hundreds of popular consumer products, vitamins,
            health supplements and prescriptive drugs.
   3)  ONE has brought to market significant products in health and
       wellness, such as the CoQ10 which is speculated to have benefits
       in migraines, cardiac arrest, blood pressure, and longevity of life,
       and 5-HTP which is used in many slimming supplements and insomnia
       prescriptive drugs.
   4)  The company reported strong third quarter 2009 (Pro Forma) results:
       Net Income was up 332.8% to $1.7 million compared to $385k for the
       same quarter last year.

"CGC has a wealth of experience and knowledge in assisting US-listed companies with operations based in China," said Marius Silvasan, CEO of ONE Bio Corp. "CGC has had many success stories with these companies and brings to our company years of established Wall Street relationships from buy-side to sell-side analysts, brokers, money managers, accredited individual investors, private equity funds and media relations."

Kevin Fickle, a partner at CGC, added, "ONE has the opportunity to leverage its existing infrastructure to increase manufacturing capacity and show tremendous bottom and top line growth through strategic acquisitions. ONE is able to produce high margin, high growth products in Asia, while maintaining a proven North American based management team. We are excited to assist ONE in its ultimate goal to maximize shareholder value."

For more information refer to also to track ONE on Twitter, Facebook and Youtube visit

About ONE Bio, Corp.

ONE Bio, Corp. ("ONE") (OTCBB: ONBI) (, headquartered in Miami, FL, is an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on capitalizing on the rapidly growing markets of the Asia Pacific region. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE's growth plan targets an aggressive acquisition driven strategy supported by strong organic growth. Through ONE, small private companies gain access to capital, experienced management and strategic insight. ONE builds strong synergies amongst all subsidiaries to enhance shareholder value. ONE is working with each subsidiary to promote organic and acquisition driven growth.

About Capital Group Communications

Capital Group Communications, Inc. ("CGC"), headquartered in the San Francisco bay area, specializes in providing brokers, fund managers and institutions with world class investor relations for premier small cap issues to high caliber global conglomerates. We create and orchestrate strategies, financial arrangements, compelling messages and persuasive stories about our partner companies' value that garners the focus that they deserve. Please visit our website and for further information on our client companies visit

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact Information